Navigation Links
Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Date:12/28/2007

(600) (2,733) (2,893)

Other Income (Expenses) (121) 348 530 (656)

Loss from Continuing

Operations (717) (252) (2,203) (3,549)

Discontinued Operations:

Loss from the

operations of BJR (1) (195) (57) (274)

Income from the

Disposal of USDTL - - - 120

Loss from

Discontinued

Operations (1) (195) (57) (154)

Net Loss $(718) $(447) $(2,260) $ (3,703)

Basic and Diluted Loss

Per Share From

Continuing Operations $(0.02) $(0.05) $(0.09) $(0.77)

Basic and Diluted Net

Loss Per Share $(0.02) $(0.08) $(0.09) $(0.80)

Weighted Average

Number of Shares and

Common Equivalent

Shares Outstanding 37,341,177 6,482,942 26,479,234 4,850,608

Selected Balance Sheet

Items-9/30/07:

Cash $94

Total Assets 1,748

Total Liabilities 8,377

Redeemable

Convertible

Preferred Stock 3,216

Shareholders' Deficit (9,846)


'/>"/>
SOURCE Avitar, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Avitars Notes Significance of New On-Site Oral Fluid Drug Testing Laws
2. Avitar Reports Third Quarter Financial Results for Fiscal 2007
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 This report is a ... industry. For an overview analysis, the report introduces ... chain structure, industry overview, policy analysis, and news ... has witnessed rapid development with key manufacturers ... This report mentions quartz tubing upstream raw materials ...
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic disease, today announced the next step in its ... bio-analytics solutions provider with the naming of current Chief ... Chief Executive Officer, while current Chairman of the Board ... serve as Chairman. These changes are effective January 1, ...
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... Nerve Repair Discussed at American Society of Plastic Surgeons ... ... With the debut of NBC,s,"Bionic Woman," the notion of a bionic ... is getting closer to reality,as reconstructive plastic surgeons perform quality-of-life-enhancing,peripheral nerve ...
... 26 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX, FSE: "HBP") today ... During the 2007 fiscal year, the Company continued ... pre-clinical (L-DOS47),development programs. The following are selected highlights during ... - Topical Interferon Alpha-2b, ...
... the first to demonstrate how an electron,s spin can ... engineers from the University of Delaware and Cambridge NanoTech ... a marathon distance in the world of microelectronics-- through ... silicon--the workhorse material of present-day electronics--now can be harnessed ...
Cached Biology Technology:Creating the Bionic Woman: Making Nerves Spring Back to Life 2Creating the Bionic Woman: Making Nerves Spring Back to Life 3Helix BioPharma Corp. announces fiscal 2007 results 2Helix BioPharma Corp. announces fiscal 2007 results 3Helix BioPharma Corp. announces fiscal 2007 results 4Helix BioPharma Corp. announces fiscal 2007 results 5Helix BioPharma Corp. announces fiscal 2007 results 6Helix BioPharma Corp. announces fiscal 2007 results 7Helix BioPharma Corp. announces fiscal 2007 results 8Helix BioPharma Corp. announces fiscal 2007 results 9Helix BioPharma Corp. announces fiscal 2007 results 10Helix BioPharma Corp. announces fiscal 2007 results 11Helix BioPharma Corp. announces fiscal 2007 results 12UD researchers race ahead with latest spintronics achievement 2
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... The fate of mature T lymphocytes might be a lot ... Center for Allergy and Immunology (RCAI) in Japan and La ... shows for the first time that mature CD4+ helper T ... and gain killing functions. The findings are reported ...
... one of the basics of neurobiology on its head ... already differentiated neuron into another within the brain. The ... maybe the brain is not as immutable as we always ... one can reprogram the identity of one neuronal class into ...
... extensive genomic study of the childhood cancer neuroblastoma ... forms of this disease. Contrary to expectations, the ... would suggest new targets for neuroblastoma treatment. Instead, ... how neuroblastoma tumors evolve in response to medicine ...
Cached Biology News:Mature T cells can switch function to better tackle infection 2Researchers turn one form of neuron into another in the brain 2Researchers turn one form of neuron into another in the brain 3Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets 2